Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: Evidence from 40,762 cases and 50,380 controls

Molecular Biology Reports

Volumn 40, Issue 6, 2013, Pages 4065-4073

  Dai, Guiping ^a   Guo, Zijian ^a   Yang, Xiaojing ^b   Yu, Bo ^a   Li, Lihua ^a  

^a Soochow University   (China)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

8q24; Breast cancer; Meta analysis; Polymorphism; rs13281615

Indexed keywords

ADENINE; BRCA1 PROTEIN; BRCA2 PROTEIN; GUANINE;

AFRICAN; ALLELE; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CASE CONTROL STUDY; CHROMOSOME 8Q; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; ETHNICITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84877729113     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2484-0     Document Type: Article

References (43)

1. Smigal C, Jemal A, Ward E, Thun M et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168-183
2. Lichtenstein P, Holm NV, Verkasalo PK et al (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
3. Ioannidis JP, Ntzani EE, Trikalinos TA et al (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
4. Dong LM, Potter JD, White E et al (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299:2423-2436
5. Ahmadiyeh N, Pomerantz MM, Grisanzio C et al (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A 107:9742-9746
6. Couch FJ, Wang X, McWilliams RR et al (2009) Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 18:3044-3048
7. Fletcher O, Johnson N, Gibson L et al (2008) Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:702-705
8. McInerney N, Colleran G, Rowan A et al (2009) Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res Treat 117:151-159
9. Turnbull C, Ahmed S, Morrison J et al (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42:504-507
10. Gudmundsson J, Sulem P, Manolescu A et al (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631-637
11. Yeager M, Chatterjee N, Ciampa J et al (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41:1055-1057
12. Al Olama AA, Kote-Jarai Z, Giles GG et al (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41:1058-1060
13. Pomerantz MM, Beckwith CA, Regan MM et al (2009) Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res 69:5568-5574
14. Lin D, Watahiki A, Bayani J et al (2008) ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res 68:4352-4359
15. Kiemeney LA, Thorlacius S, Sulem P et al (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40:1307-1312
16. Zanke BW, Greenwood CM, Rangrej J et al (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39:989-994
17. Tenesa A, Farrington SM, Prendergast JG et al (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40:631-637
18. Li L, Plummer SJ, Thompson CL et al (2008) A common 8q24 variant and the risk of colon cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 17:339-342
19. Poynter JN, Figueiredo JC, Conti DV et al (2007) Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the colon cancer family registry. Cancer Res 67:11128-11132
20. Tomlinson I, Webb E, Carvajal-Carmona L et al (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39:984-988
21. Gruber SB, Moreno V, Rozek LS et al (2007) Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer Biol Ther 6:1143-1147
22. Girard L, Zochbauer-Muller S, Virmani AK et al (2000) Genomewide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60:4894-4906
23. Park SL, Chang SC, Cai L et al (2008) Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev 17:3193-3202
24. Ghoussaini M, Song H, Koessler T et al (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100:962-966
25. Domagk D, Schaefer KL, Eisenacher M et al (2007) Expression analysis of pancreatic cancer cell lines reveals association of enhanced gene transcription and genomic amplifications at the 8q22.1 and 8q24.22 loci. Oncol Rep 17:399-407
26. Shete S, Hosking FJ, Robertson LB et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904
27. Schoemaker MJ, Robertson L, Wigertz A et al (2010) Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol 171:1165-1173
28. Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093
29. Antoniou AC, Sinilnikova OM, McGuffog L et al (2009) Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 18:4442-4456
30. Latif A, Hadfield KD, Roberts SA et al (2010) Breast cancer susceptibility variants alter risks in familial disease. J Med Genet 47:126-131
31. Gorodnova TV, ESh Kuligina, Yanus GA et al (2010) Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women. Cancer Genet Cytogenet 199:69-72
32. Barnholtz-Sloan JS, Shetty PB, Guan X et al (2010) FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 31:1417-1423
33. Shan J, Mahfoudh W, Dsouza SP et al (2012) Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Breast Cancer Res Treat 135:715-724
34. Campa D, Kaaks R, Le Marchand L et al (2011) Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103:1252-1263
35. Garcia-Closas M, Hall P, Nevanlinna H et al (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4:e1000054
36. Harlid S, Ivarsson MI, Butt S et al (2012) Combined effect of low-penetrant SNPs on breast cancer risk. Br J Cancer 106:389-396
37. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
38. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
39. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
40. Egger M, Davey SG, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
41. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130
42. Begg CB, Haile RW, Borg A et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299:194-201
43. Hopper JL, Southey MC, Dite GS et al (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol Biomarkers Prev 8:741-747